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ARTICLE OPEN
Suspected community-acquired pneumonia in an ambulatory
setting (CAPA): a French prospective observational cohort
study in general practice
Henri Partouche1, Céline Buffel du Vaure1, Virginie Personne1, Chloé Le Cossec2, Camille Garcin2, Alain Lorenzo1,
Christian Ghasarossian1,3, Paul Landais4,6, Laurent Toubiana5,6 and Serge Gilberg1
BACKGROUND: Few studies have addressed the pragmatic management of ambulatory patients with suspected community-
acquired pneumonia (CAP) using a precise description of the disease with or without chest X-ray (X-ray) evidence.
AIMS: To describe the characteristics, clinical ﬁndings, additional investigations and disease progression in patients with suspected
CAP managed by French General Practitioners (GPs).
METHODS: The patients included were older than 18 years, with signs or symptoms suggestive of CAP associated with recent-onset
unilateral crackles on auscultation or a new opacity on X-ray. They were followed for up to 6 weeks. Descriptive analyses of all
patients and according to their management with X-rays were carried out.
RESULTS: From September 2011 to July 2012, 886 patients have been consulted by 267 GPs. Among them, 278 (31%) were older
than 65 years and 337 (38%) were at increased risk for invasive pneumococcal disease. At presentation, the three most common
symptoms, cough (94%), fever (93%), and weakness or myalgia (81%), were all observed in 70% of patients. Unilateral crackles were
observed in 77% of patients. Among patients with positive radiography (64%), 36% had no unilateral crackles. A null CRB-65 score
was obtained in 62% of patients. Most patients (94%) initially received antibiotics and experienced uncomplicated disease
progression regardless of their management with X-rays. Finally, 7% of patients were hospitalised and 0.3% died.
CONCLUSIONS: Most patients consulting GPs for suspected CAP had the three following most common symptoms: cough, fever,
and weakness or myalgia. More than a third of them were at increased risk for invasive pneumococcal disease. With or without
X-rays, most patients received antibiotics and experienced uncomplicated disease progression.
npj Primary Care Respiratory Medicine (2015) 25, 15010; doi:10.1038/npjpcrm.2015.10; published online 12 March 2015
INTRODUCTION
Early diagnosis of community-acquired pneumonia (CAP) is
essential for prompt initiation of an empirical antimicrobial
therapy as stated in guidelines to improve patient outcomes.1–3
However, the diagnosis of CAP can be complex, as it is often
based on a combination of clinical symptoms, radiographic,
laboratory and microbiological ﬁndings, and the clinical response
to antimicrobial therapy. Previous reviews have shown that patient
history and physical examination are not sufﬁcient to reliably
differentiate CAP from other lower respiratory tract infections.4–6
Consequently, ﬁndings suggestive of pneumonia on chest X-ray
(X-ray) are considered a gold standard and are recommended in
order to conﬁrm the diagnosis.1–3
In primary care, patients frequently consult in the early stage of
the disease and the clinical ﬁndings classically described are thus
seldom all present. An X-ray is not always taken for patients, nor is
it a part of the General Practitioner's (GP's) decision-making
process.7 Moreover, the optimal usefulness of an X-ray in the
assessment of suspected CAP is not consensual between all
guidelines.1–3,8,9
To our knowledge, no large studies taking into account the
pragmatic management of patients with suspected CAP in
ambulatory practice have primarily focussed on a precise
description of the disease. Furthermore, most ambulatory studies
have focussed on symptoms and signs of conﬁrmed CAP using
X-rays in patients consulting their GP for cough or lower
respiratory tract infection symptoms and not in patients with
suspected CAP.10–13
The primary objective of this study was to describe patients
with clinical ﬁndings suggestive of CAP and managed in general
practice in terms of past history, presenting manifestations, clinical
ﬁndings, radiological and/or biological results and disease
progression (recovery, hospitalisation or death). The secondary
objective was to describe patients according to their management
with or without X-rays.
MATERIALS AND METHODS
This prospective cohort study was conducted between 21 September 2011
and 2 July 2012. A network of 475 French GPs had to include consecutively
all adult outpatients with suspected CAP. Data were collected in an
electronic case report form (eCRF).
Study population
All investigators were part of a national GP network involved in clinical
research. They were recruited through a website linked to the eCRF.
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A stratiﬁed random sampling based on a multistage geographical cluster
at a departmental level was used.
Patient inclusion criteria were as follows: age older than 18 years and
having recently experienced one or more signs suggestive of acute
pneumonia, such as fever 438.5 °C, cough, chest pain, tachycardia 4100
beats/min, tachypnoea425 breaths/min, and clinical global impression of
severity. These criteria had to be associated with one focus of recent-onset
unilateral crackles on auscultation. In the absence of unilateral crackles, a
new opacity on X-ray was mandatory to deﬁnitely include the patient. For
this purpose, a pre-inclusion process was possible in the eCRF until a
positive X-ray was obtained. Then, GPs could register patient character-
istics and clinical ﬁndings recorded at the initial visit.
Patients hospitalised in the previous month were not included. Patients
who fulﬁlled the inclusion criteria had to sign an informed consent form
before data collection during the baseline visit. As patients were followed
in the context of current patient management practices, investigations and
treatments were at the GP's initiative. The number of follow-up visits was
not pre-speciﬁed. Only the ﬁnal visit (by consultation or telephone contact)
was mandatory and had to be done between the fourth and sixth week
following inclusion (regardless of whether the patient had recovered).
Data collection
The collected data included visit date, age, gender, lifestyle, history and
clinical ﬁndings, investigations and their results, treatments, reasons for
reconsulting, duration of main symptoms, sick leave and its duration if
present, hospitalisation and death. Patient data were de-identiﬁed.
We considered patients at increased risk for invasive pneumococcal
disease as those with chronic respiratory disease (COPD, emphysema,
chronic bronchitis, chronic pulmonary failure), asthma, chronic heart
failure, nephrotic syndrome, aspleny or splenectomy, homozygous sickle
cell disease, HIV infection, diabetes mellitus or previous history of
pneumonia.14,15 Severity was assessed using the ﬁve-point CRB-65 score
including confusion, respiratory rate ⩾ 30/min, systolic blood pressure
o90mmHg or diastolic blood pressure ⩽ 60mmHg and age ⩾ 65 years.16
A positive radiograph was deﬁned by the presence of focal alveolar
opacity or multiple, mottled, peribronchial opacities or localised or diffuse
interstitial opacities. A negative radiograph was deﬁned by normal or
nonspeciﬁc radiographic ﬁndings and/or isolated pleural effusion.4,8
Two clinical research associates performed a data quality control process
during the whole study period. They focussed their control on record
completeness and data collection from additional investigations. The
monitoring team ensured that inclusion criteria were met, particularly in
patients without X-ray or with negative radiography to rule out bronchitis
or crackles due to other causes.
A periodical online newsletter was sent to the investigators to avoid
patients lost to follow-up.
Data analysis
Continuous data are presented as mean (standard deviation) for
parametric distributions, or as median [interquartile range] for non-
parametric distributions. Categorical data are presented as frequencies
(percentages). Percentages were calculated on data available; the
percentage of unavailable data (%NA) is provided for each variable in
the tables. Percentages were compared using Pearson’s Chi-square test
and means using Student’s t-test. All the tests were two-sided and
performed with a 5% type-I error. The analysis was performed using R 3.0.2
Software.17
Study sample size
Assuming that patients with X-rays should represent 60% of the sample7
and that 10% of patient records could be incomplete, a sample of 1,056
patients consisting of 634 patients with X-rays were therefore necessary to
have a power of 90% leading to a precision of 5% in descriptive statistics
with a type-I error of 5%.
RESULTS
Within the national training network, 425 selected investigators
accepted to participate and 267 (63%) included at least one
patient (Figure 1, Table 1). Between 21 September 2011 and 2 July
2012, 886 patients with suspected CAP were included. Data
collected at the ﬁnal visit were available for 865 patients (Figure 2).
Characteristics and past history
The median age of the patients was 55 (18–102) years and 278
(31%) were older than 65. Among the patients included, 314 (35%)
were retired, 43 (5%) received free health care (low income),
27 (3%) were unemployed or disabled and 25 (3%) were students.
Four hundred and ﬁve (46%) patients reported no medical history,
whereas 337 (38%) patients were at increased risk for invasive
pneumococcal disease. Other main results are presented in
Table 2. In addition, 58 (7%) were diabetic, 28 (3%) were treated
with long-term steroids or immunosuppressive agents and
53 (6%) with long-term psychotropic drugs. Two hundred and
three (23%) patients had received an inﬂuenza vaccine for the
season 2011–2012 and 94 (11%) a 23-valent pneumococcal
polysaccharide vaccine.
Symptoms and physical signs at inclusion
Sudden onset of symptoms was reported by 62% of patients and
the median time before consulting was 4 (2–7) days. The three
Departental distribution of French GPs (N =61,000).
Conseil National de I’Ordre des Médecins 2012†
† Conseil National de l’Ordre des Médecins. Atlas National 2012 (cited 12 January 2014). Available on:
http://www.conseil-national.medecin.fr/demographie/atlas-national-873
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least one patient (N = 267)
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Figure 1. Departmental distribution of investigators who participated in the CAPA study. CAPA, community-acquired pneumonia in an
ambulatory setting; GP, general practitioner.
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most common symptoms at presentation were cough, tempera-
ture437.8 °C and weakness or myalgia (Table 2). Among the 798
patients with data available, 558 (70%) experienced all three of the
most common symptoms.
On chest auscultation, 95 (11%) patients had normal breath
sounds and 709 (80%) had crackles, including 684 (77%) with
unilateral crackles and 273 (31%) with unilateral isolated crackles.
Among patients with crackles, 245 (28%) had rhonchi and 150
(17%) had wheezing.
A clinical global impression of severity was reported in
240 (27%) patients. When calculating the Gennis’ prediction
rule,18 744 (92%) patients had at least one altered vital sign
(bottom of Table 2).
Confusion and hypotension (systolic blood pressure o90mmHg
or diastolic blood pressure ⩽ 60mmHg) were observed in 16 (2%)
and 8 (1%) patients, respectively. Among the 642 patients with
data available, 399 (62%) patients obtained a null score on the
CRB-65.16 Other results are presented in Table 2.
Additional medical investigations
One hundred and seventy-two (19%) patients were managed
without X-rays. Among the 714 patients with X-rays, 233 (33%)
underwent it within 3 days following their inclusion visit and the
remaining patients after 3 days. The median time to obtain a
positive and negative radiographic result was 5 (3–9) and 6 (4–11)
days, respectively. Finally, 563 (64%) patients presented a positive
radiograph, including 202 (36%) patients without unilateral
crackles. Among the 558 patients who had all three most
common symptoms, 447 (80%) had undergone a chest X-ray,
which was positive in 356 (80%).
White blood cell count was taken in 316 (36%) patients;
C-reactive protein (CRP) level was assessed in 314 (35%)
patients; and procalcitonin level was evaluated in 13 (1%) patients.
Legionella and Streptococcus pneumoniae urinary antigens were
searched in 2 and 0% of patients, respectively.
Treatments prescribed at the inclusion visit
Most patients (94%) were prescribed an antibiotic at the inclusion
visit. A ﬁrst-line monotherapy with amoxicillin, co-amoxi-clavulanic
acid, macrolide and pristinamycin was prescribed to 357 (43%),
251(30%), 88 (10%) and 49 (6%) patients, respectively. The median
dose and duration of amoxicillin treatment were 3 g/day for
10 days. Among the patients not treated with amoxicillin or
co-amoxi-clavulanic acid, 35 (23%) were allergic to penicillin.
A ﬁrst-line bitherapy was prescribed for 34 (4%) patients and
included a macrolide in 21 (2%) patients.
Follow-up, evolution and death
Five hundred and seventeen (58%) and 120 (13%) patients had
one and two follow-up visits, respectively. The median duration
Table 1. Characteristics of GPs who included at least one patient (active), GPs who did not (non-active) and the National demography of French GPs
Active GPs (n=267) n (%) Non-active GPs (n=158) n (%) P value National demographya (%)
Gender
Women 80 (30.0) 39 (24.7) NS (41.2)
Age
30–39 years 54 (20.2) 26 (16.4) (17.7)
40–49 years 67 (25.1) 34 (21.5) (28.1)
50–59 years 105 (39.3) 76 (48.1) NS (37.6)
Older than 60 years 41 (15.4) 22 (13.9) (16.6)
Location
Rural o5,000 inhabitantsb 80 (30.0) 52 (32.9) (12.1)
Semi-rural 71 (26.6) 31 (19.6) NS (16.6)
Urban 420,000 116 (43.4) 75 (47.5) (71.3)
Group practice 191 (71.5) 31 (19.6) o0.001 (45.3)
Teaching physician 238 (89.1) 136 (86.1) NS (9.5)
No alternative medicinec 253 (94.8) 155 (98.1) NS (90.1)
Abbreviations: GP, general practitioner; NS, not signiﬁcant.
aSicart D. Direction de la recherche, des études, de l’évaluation et des statistiques (DREES). Ministère du travail, de l'emploi et de la santé. Les médecins au 1er
janvier 2012. Available on: http://www.drees.sante.gouv.fr/les-professions-de-sante-au-1er,10930.html. Accessed 14 July 2014.
bLiving in a city of o5,000 inhabitants.
cNo partial activity of acupuncture or homoeopathy or osteopathy.
Assessed for eligibility
n =982
Not included: n =96
-   Ineligible patients
o  Did not fulfil inclusion criteria(65)
o  Other diagnosis (9)
-   Eligible but not enrolled
o  No inaugural diagnosis (5)
o  Diagnosis outside the study period (10)
o  GP withdrawal=7
Without final visit
n =21
Data analysed
data available at the first
visit
n =886
Patients with complete follow-up
n =865
Figure 2. Flowchart of patients included. GP, general practitioner.
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between the inclusion visit and the ﬁrst follow-up visit was 7
(3–11) days. Among the patients who had a ﬁrst follow-up visit,
83 (16%) had a change in their antimicrobial therapy that
included 20 (4%) additions of a second antibiotic and 64 (12%)
antibiotic switches, including 13 (3%) switches from amoxicillin or
co-amoxi-clavulanic acid to a macrolide.
Finally, 62 (7%) patients were hospitalised and 3 (0.3%) died
during the follow-up period. Patients at increased risk for invasive
pneumococcal disease and patients with CRB-65 score ⩾ 1 were
more often hospitalised than others (respectively, 10 vs. 5%,
P= 0.002, and 13 vs. 3%, Po0.001). Other results are presented in
Table 3.
Table 2. Characteristics, symptoms, signs at inclusion of all patients and patients with positive, negative and without chest radiographs
All included patients,
N= 886
No chest radiography,
N=172
Positive chest
radiography, N= 563
Negative chest
radiography, N=151
P value
n (%)a or mean
[s.d.]
NAb (%) n (%)a or mean
[s.d.]
NAb (%) n (%)a or mean
[s.d.]
NAb (%) n (%)a or mean
[s.d.]
NAb (%)
Gender, female 467 (53) — 91 (53) — 299 (53) — 77 (51) — 0.89
Age ⩾ 65 years 278 (31) — 70 (41) — 154 (27) — 54 (36) — o0.01
BMI (kg/m2) 25 [5] (5.3) 25 [5] (5.8) 25 [5] (4.8) 26 [5] (6.3) o0.01
Location: rural o5,000
inhabc
366 (41) — 77 (45) — 227 (40) — 62 (41) — 0.67
Children younger than
5 years at home
182 (21) (0.9) 24 (14) (1.2) 130 (23) (0.5) 28 (19) (2.0) 0.23
Home-dependent patients 46 (5) — 14 (8) — 25 (4) (0.2) 7 (5) — 0.15
Previous 23-valent PPV 94 (11) — 19 (11) — 59 (10) — 16 (11) — 0.41
Smoker 205 (23) (0.5) 49 (28) — 116 (21) (0.7) 40 (26) — 0.12
Previous CAP 124 (14) — 29 (17) — 82 (15) — 13 (9) — 0.08
Asthma 100 (11) — 19 (11) — 56 (10) — 25 (17) — 0.07
Chronic respiratory disease 118 (13) — 38 (22) — 57 (10) — 23 (15) — o0.01
Heart failure 42 (5) — 11 (6) — 22 (4) — 9 (6) — 0.30
Cough 833 (94) — 163 (95) — 523 (93) — 147 (97) — 0.10
Weakness or myalgia 718 (81) — 137 (80) — 465 (83) — 116 (77) — 0.24
Chills 616 (70) (0.1) 115 (67) — 399 (71) (0.2) 102 (68) — 0.49
Sputum or phlegm 505 (57) (0.1) 115 (67) — 288 (51) (0.2) 102 (68) — o0.01
Dyspnoea 414 (47) (0.1) 80 (47) (0.6) 250 (44) — 84 (56) — 0.04
Unilateral chest pain 335 (38) (0.1) 79 (46) (0.6) 185 (33) — 71 (47) — o0.01
Runny nose 261 (29) (0.1) 54 (31) — 153 (27) (0.2) 54 (36) — 0.10
Wheezing perceived by
patients
187 (21) (0.1) 47 (27) (0.6) 95 (17) — 45 (30) — o0.01
Maximal declared
temperature (°C)
39 [1] (14.1) 39 [1] (17.4) 39 [1] (12.1) 39 [1] (17.9) 0.04
Temperature (measured or
reported) 437.8 °C
700 (93) (15.1) 132 (95) (19.2) 454 (92) (12.8) 114 (94) (19.2) 0.60
Tachycardia (⩾100 beats/
min)
126 (15) (5.8) 32 (20) (7.0) 74 (14) (5.5) 20 (14) (5.3) 0.15
Unilateral crackles 684 (77) — 172 (100) — 361 (64) — 151 (100) — o0,01
Bilateral crackles 27 (3) — 0 (0) — 25 (4) — 0 (0) — —
Unilateral decreased
vesicular breathing
222 (25) — 44 (29) — 131 (23) — 47 (27) — 0.25
Wheezes 166 (19) — 43 (25) — 89 (16) — 34 (23) — 0.01
Rhonchi 289 (33) — 62 (36) — 185 (33) — 42 (28) — 0.28
Gennis’ scored= 0
(no vital sign)
67 (8) (8.5) 12 (8) (10.5) 41 (8) (8.0) 14 (10) (7.9) 0.69
CRB-65 scoree= 0 399 (62) (27.4) 65 (55) (31.4) 269 (66) (29.0) 65 (57) (24.5) 0.08
= 1 205 (32) 41 (35) 120 (29) 44 (39)
= 2 32 (5) 9 (8) 18 (4) 5 (4)
= 3 6 (1) 3 (3) 3 (1) 0 (0)
C-reactive protein
o20mg/l
74 (23) (63.8) 3 (11) (84.3) 53 (22) (57.2) 18 (34) (64.9) 0.16
20–100mg/l 118 (37) 12 (44) 87 (36) 19 (36)
4100mg/l 129 (40) 12 (44) 101 (42) 16 (30)
White blood cells count
410,000/mm3
143 (44) (63.5) 13 (50) (84.9) 104 (43) (57.2) 26 (46) (62.9) 0.75
Univariate analysis in the population with chest radiography.
Abbreviations: BMI, body mass index; CAP, community-acquired pneumonia; PPV, pneumococcal polysaccharide vaccine.
aPercentages are calculated on available data.
bData not available.
cLiving in a city of o5,000 inhabitants (inhab).
dScore18: 1 point for each feature: confusion, respiratory rate ⩾ 30/min, systolic blood pressure o90mmHg or diastolic blood pressure ⩽ 60mmHg, age
⩾ 65 years.
eScore17: 1 point for each feature:temperature 437.8 °C, pulse 4100 beats/min, respiratory rate 420/min.
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Description of subgroups according to the use of chest
radiography
Patients older than 65 years were more often managed without
having undergone an X-ray (25 vs. 17% for patients younger than
65, Po0.003). Among patients managed with X-rays, those older
than 65 years had a negative chest radiography more frequently
compared with patients younger than 65 years (26 vs.19%;
P= 0.04). Other results related to patient characteristics at the
inclusion visit and disease progression are presented in Table 2
and Table 3, respectively.
DISCUSSION
Main ﬁndings
In this cohort of 886 patients with suspected CAP, 31% were older
than 65 years and 38% were at increased risk for invasive
pneumococcal disease. At presentation, most patients had cough,
fever, and weakness or myalgia, and 70% of them experienced all
three of these most common symptoms. Most patients (92%) had
at least one vital sign altered, 77% had unilateral crackles and 11%
had no abnormality on chest auscultation. Among the 563 (64%)
patients who had positive radiography, one third had no unilateral
crackles. Two thirds of patients with data available obtained a null
CRB-65 score. Regardless of their management with X-rays, most
patients received antibiotics and most experienced an uncompli-
cated disease progression,
Interpretation of ﬁndings in relation to previously published work
Clinical ﬁndings. In our population, cough and fever, two of the
three most common symptoms observed, were very frequent, as
previously reported in other studies that also included patients
with suspected CAP.7,19 Concomitantly, we found that sputum
production, dyspnoea and unilateral chest pain, which are
common clinical features of conﬁrmed CAP, were less frequently
present, but these results were in accordance with those of a
previous study.20 The proportion of patients with unilateral
crackles on chest auscultation was high (77%) but comparable
to the result of a study with similar design.7 When considering
only patients with positive radiography, the proportion of patients
with unilateral crackles remained high (64%) compared with those
reported in previous studies conducted on patients with lower
respiratory tract infection: 20%11 and up to 32%10 in patients with
new pulmonary inﬁltrate. This could be due to our inclusion
criteria that favoured the selection of patients with unilateral
crackles on chest auscultation. It is likely that most GPs could not
determine whether the crackles were recent or chronic. However,
these results conﬁrm that, although crackles are an essential
diagnostic criterion, they have limited value in predicting a
pulmonary inﬁltrate when they are used alone.6
Contribution of chest radiography and co-morbidity. Our investi-
gators were allowed to pragmatically manage their patients in
accordance with the European guidelines in which an X-ray is not
systematically included in the management of patients with
suspected CAP.8,9 However, using an X-ray remains the corner-
stone of the diagnosis according to French guidelines, which
include an inﬁltrate on X-ray in the deﬁnition of CAP.1,2 It is
probably the reason why GPs, among whom 89% were medical
trainers, used X-rays in most patients (80%) and probably not in
selected patients with uncertain diagnosis or progressive disease
or at risk for underlying lung pathology.9
Dyspnoea, described elsewhere as a predictor of pulmonary
inﬁltrate in patients with lower respiratory tract infection,10,21 was
less frequently observed in patients with positive radiography
than in patients with negative radiography (44 vs. 56%, P= 0.04;
Table 2). Similar results were observed for unilateral chest painT
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and for sputum or phlegm (33 vs. 47%, Po0.01, and 51 vs. 68%,
Po0.01).
Our inclusion critera could have led GPs to include more
patients with dyspnoea, unilateral chest pain and sputum among
patients with negative radiography as patients with atypical
symptoms (without crackles) had to have a mandatory positive
radiography to be included. However, results for sputum are
consistent with those of Hopstaken et al., who have identiﬁed dry
cough as an independent and signiﬁcant predictor of pulmonary
inﬁltrate.22 Wheezing, a common symptom of COPD known to
interfere with the clinical features of pneumonia,23 was also less
frequently observed in patients with positive radiography (17 vs.
30%, Po0.01). Similarly, there were fewer patients older than 65
years and with chronic respiratory disease among those with
positive radiography than among those with negative radiography
(respectively, 27 vs. 36%, P= 0.02, and 10 vs. 15%, Po0.01).
However, there were close but low proportions of patients without
‘vital signs’ of the Gennis’ score18 among those with either positive
or negative radiography or without X-rays (Table 2). These results
suggest that X-rays have limited value in ruling out pneumonia,24
especially in patients with chronic respiratory disease and in
elderly patients.
Antibiotic treatments. A systematic treatment with antibiotics
was observed in our population, regardless of the prognostic
factors. In fact, 69% of patients were younger than 65 years, 46%
had no former medical history, and 62% of patients with data
available obtained a null CRB-65 score. The median dose and
duration of the most prescribed antibiotic (amoxicillin, 1 g three
times daily for 10 days) were higher and longer than those
recommended by the UK Guidelines9 (amoxicillin, 500mg three
times daily for 7 days). Most GPs were probably convinced to treat
patients with CAP and strictly met the French Guidelines, which
emphasise the importance of initiating high-dose amoxicillin
within 4 h after diagnosis.1,2 However, this strategy, which is not
recommended in several European countries, remains question-
able as long-term treatment could be linked to the emergence
and selection of resistant bacteria25 and this dosage is associated
with a higher incidence of gastritis and diarrhoea.26
Disease progression. Most patients had mild disease with
uncomplicated progression during the follow-up period, regard-
less of their management with X-rays. We can assume that
patients presenting with severe disease could have consulted at
the emergency departments. However, our proportions of
hospitalisation and death were consistent with those reported in
a previous population-based study.27 In addition, our results
conﬁrm the importance of identifying patients at increased risk for
invasive pneumococcal disease14,15 or with high CRB-65 score16 as
these patients were more often hospitalised in our population.
Strengths and limitations of this study
The main strengths of our study were its design and sample size.
Our inclusion criteria were close to those of the current practice as
they allowed GPs to include patients without any context of
cough. Investigators were evenly distributed throughout France.
Compared with the national medical demography,28,29 the rates of
men, medical trainers, rural location or group exercise were larger
in our group of investigators (Table 1). The patients included
mainly lived in a rural or semi-urban environment and their socio-
professional distribution was similar to the French demographic
distribution.30
However, our study has some limitations. First, the investigators
were part of a trainer and research GP network. Thus, the
representativeness of the GP practice could be questioned.
However, it has been shown that results of practice-based
research networks are relevant to other practising clinicians.31
Second, according to our inclusion criteria, an X-ray was not
performed in all patients. GP decision-making process, care
conditions, patient preferences and other causes could have
inﬂuenced the decision to perform or not perform an X-ray.32 We
did not ask the investigators the reason for prescribing or not
prescribing an X-ray as our objectives were focussed on patient
characterisation.
Furthermore, when an X-ray was performed, the interpretation
by a local radiologist aware of the suspected diagnosis could have
contributed to overdiagnosis, particularly in case of non-alveolar
pneumonia.33 However, as our study took place in the ambulatory
setting, forcing a strict timing to perform the CR associated with a
double reading was not consistent with the current practice.
In patients with negative radiography but with clinical ﬁndings
consistent with CAP, false negatives with delayed positivity were
possible. However, the median time for obtaining negative
radiography results following the inclusion was 6 days and only
33 patients had a negative X-ray within the 3 days following the
inclusion. Moreover, obtaining a normal X-ray despite pulmonary
infection conﬁrmed microbiologically or by chest CT has been
previously described.34
Implications for future research, policy and practice
Our ﬁndings support the questionable usefulness of the routine
X-ray in the management of patients with suspected CAP.35
Further ambulatory studies with microbiological investigations
and/or biological markers are needed to help GPs in their decision
to prescribe antibiotics.
Conclusions
At ﬁrst presentation, most patients consulting GPs for suspected
CAP had a sudden onset of cough, fever, and weakness or
myalgia. All of these three most common symptoms were found
in 70% of patients. Most patients had mild disease even if a
signiﬁcant proportion of them were at increased risk for invasive
pneumococcal disease. However, systematic antibiotic prescrip-
tion, with mainly high-dose amoxicillin, was observed in this
population. Regardless of their management with X-rays, most
patients experienced an uncomplicated disease progression.
These ﬁndings conﬁrm the low relevance of a routine X-ray in
assessing suspected CAP in primary care.
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